Adjuvant transarterial chemoembolization with sorafenib for patients with hepatocellular carcinoma with portal vein tumor thrombus after surgery: A phase III, multicenter, randomized, controlled trial.-MedSci.cn

Adjuvant transarterial chemoembolization with sorafenib for patients with hepatocellular carcinoma with portal vein tumor thrombus after surgery: A phase III, multicenter, randomized, controlled trial.

Kuang, M; Peng, ZW; Fan, WZ; Liu, ZL; Xiao, H; Tu, JF; Tang, R; Huang, Z; Cheng, Y; Li, FL; Lu, MJ; Li, JP

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (): 493

科室
- - 订阅+
  - 更多科室
工具
服务